Showing results (1-10 of 19) with videos related to
Sort By:
Pageof 2
Biology Direct|February 9, 2010
FOXP3 and GARP (LRRC32): the master and its minionMichael Probst-Kepper, Jan BuerAnasthesiologie, Intensivmedizin, Notfallmedizin, Schmerztherapie : AINS|July 24, 2018
[New Antibiotics for Treatment of Highly Resistant Gram-negative Bacteria]Michael Probst-Kepper, Gernot GeginatTransfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|June 7, 2012
FOXP3 Expression in GARP-Transduced Helper T Cells Is Not Associated with FOXP3 TSDR DemethylationJan Kehrmann, Michael Zeschnigk, Jan Buer, et al.Immunological Reviews|November 26, 2002
Changes in actin dynamics at the T-cell/APC interface: implications for T-cell anergy?Antonio S Sechi, Jan Buer, Jürgen Wehland, et al.Deutsche Medizinische Wochenschrift (1946)|February 13, 2024
[Diagnostic stewardship in outpatient and hospital medicine with focus on microbiological urinary and bloodstream diagnostics]Reinhard Bornemann, Johannes Hartmann, Olaf Kaup, et al.Transfusion Medicine and Hemotherapy : Offizielles Organ Der Deutschen Gesellschaft Fur Transfusionsmedizin Und Immunhamatologie|November 16, 2010
Perspectives on Regulatory T Cell TherapiesMichael Probst-Kepper, Andrea Kröger, Henk S P Garritsen, et al.Plos One|December 5, 2012
Quantification of regulatory T cells in septic patients by real-time PCR-based methylation assay and flow cytometryRoman Tatura, Michael Zeschnigk, Michael Adamzik, et al.Plos One|July 21, 2012
First insight into the kinome of human regulatory T cellsSebastian König, Michael Probst-Kepper, Tobias Reinl, et al.Immunology|January 31, 2014
Impact of 5-aza-2'-deoxycytidine and epigallocatechin-3-gallate for induction of human regulatory T cellsJan Kehrmann, Roman Tatura, Michael Zeschnigk, et al.Blood|August 25, 2005
1alpha,25-Dihydroxyvitamin D3 is a potent suppressor of interferon gamma-mediated macrophage activationLaura Helming, Jens Böse, Jan Ehrchen, et al.Pageof 2